Dolo V - Search Results

1

Leukocyte depletion does not affect the in vitro healing ability of platelet rich plasma.

Giusti I, Di Francesco M, D'Ascenzo S, Palumbo P, Rughetti A, Dell'Orso L, Varasano PA, Pressanti GL, Dolo V. Giusti I, et al. Among authors: dolo v. Exp Ther Med. 2018 Apr;15(4):4029-4038. doi: 10.3892/etm.2018.5887. Epub 2018 Feb 22. Exp Ther Med. 2018. PMID: 29556269 Free PMC article.

2

Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A. Dolo V, et al. Clin Exp Metastasis. 1999 Mar;17(2):131-40. doi: 10.1023/a:1006500406240. Clin Exp Metastasis. 1999. PMID: 10411105

3

New approaches to the study of sphingolipid enriched membrane domains: the use of electron microscopic autoradiography to reveal metabolically tritium labeled sphingolipids in cell cultures.

Dolo V, D'Ascenzo S, Sorice M, Pavan A, Sciannamblo M, Prinetti A, Chigorno V, Tettamanti G, Sonnino S. Dolo V, et al. Glycoconj J. 2000 Mar-Apr;17(3 -4):261-8. doi: 10.1023/a:1026505710607. Glycoconj J. 2000. PMID: 11201799

4

Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Angelucci A, D'Ascenzo S, Festuccia C, Gravina GL, Bologna M, Dolo V, Pavan A. Angelucci A, et al. Among authors: dolo v. Clin Exp Metastasis. 2000;18(2):163-70. doi: 10.1023/a:1006778000173. Clin Exp Metastasis. 2000. PMID: 11235992

5

Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.

Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Taraboletti G, et al. Among authors: dolo v. Am J Pathol. 2002 Feb;160(2):673-80. doi: 10.1016/S0002-9440(10)64887-0. Am J Pathol. 2002. PMID: 11839588 Free PMC article.

6

Induction of a multifactorial resistance phenotype by high paclitaxel selective pressure in a human ovarian carcinoma cell line.

Violini S, D'Ascenzo S, Bagnoli M, Millimaggi D, Miotti S, Canevari S, Pavan A, Dolo V. Violini S, et al. Among authors: dolo v. J Exp Clin Cancer Res. 2004 Mar;23(1):83-91. J Exp Clin Cancer Res. 2004. PMID: 15149155

7

Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment.

D'Ascenzo S, Giusti I, Millimaggi D, Marci R, Tatone C, Cardigno Colonna R, Moscarini M, Pavan A, Dolo V, Caserta D. D'Ascenzo S, et al. Among authors: dolo v. Eur J Endocrinol. 2004 Jul;151(1):87-91. doi: 10.1530/eje.0.1510087. Eur J Endocrinol. 2004. PMID: 15248826

8

Shedding of membrane vesicles by tumor and endothelial cells.

Dolo V, D'Ascenzo S, Giusti I, Millimaggi D, Taraboletti G, Pavan A. Dolo V, et al. Ital J Anat Embryol. 2005;110(2 Suppl 1):127-33. Ital J Anat Embryol. 2005. PMID: 16101030

9

Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells.

Millimaggi D, Festuccia C, Angelucci A, D'Ascenzo S, Rucci N, Flati S, Bologna M, Teti A, Pavan A, Dolo V. Millimaggi D, et al. Among authors: dolo v. Int J Oncol. 2006 Apr;28(4):909-14. Int J Oncol. 2006. PMID: 16525640

10

Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH.

Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A, Dolo V. Taraboletti G, et al. Among authors: dolo v. Neoplasia. 2006 Feb;8(2):96-103. doi: 10.1593/neo.05583. Neoplasia. 2006. PMID: 16611402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters